Gallery
- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
Olympic bronze medallist Bajrang Punia has been provisionally suspended by the National An
- Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards
- Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics
- Lione Messi said Retirement not on my mind
- Indian Wells: Alcaraz, Swiatek win titles
- African footballer chased and thrashed away in Kerala; reports
USA sends Brazil 2 million HCQ doses Last Updated : 01 Jun 2020 12:28:41 PM IST HCQ USA has sent 2 million doses of hydroxychloroquine (HCQ) to Brazil, the two governments have confirmed, days after the World Health Organization (WHO) halted the anti-malaria drug's clinical trials over safety concerns.
"The US will also soon be sending 1,000 ventilators to Brazil," a joint statement said which was released by the White House on Sunday.WHO Director-General Tedros Adhanom Ghebreyesus said recently that a clinical trial of HCQ on COVID-19 patients came to "a temporary pause" while the safety data is reviewed by the Data Safety Monitoring Board, reports Xinhua news agency.The Lancet medical journal has published an observational study on HCQ and chloroquine, in which the authors of the study reported that among patients receiving either of the drugs, when used alone or with a macrolide, they estimated a higher mortality rate.IANS Washington For Latest Updates Please-
Join us on
Follow us on
172.31.16.186